Gi Cancer Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Imfinzi Plus Chemotherapy Approved for Advanced Biliary Tract Cancer

The FDA has approved Imfinzi (durvalumab), in combination with gemcitabine and cisplatin, for the treatment of biliary tract cancer.

Medstar georgetown university hospitalDistrict of columbiaUnited statesGeorgetown lombardi comprehensive cancer centerGi cancer programDrug administrationAssociate professor

FDA Approves Imfinzi Plus Chemotherapy for Patients with Advanced Biliary Tract Cancer

FDA Approves Imfinzi Plus Chemotherapy for Patients with Advanced Biliary Tract Cancer
globalgenes.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globalgenes.org Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomMedstar georgetown university hospitalDistrict of columbiaSouth koreaDave fredricksonAstrazeneca imfinziSouth east asiaGi cancer programDrug administrationRegulatory agencySingapore health sciences authorityAustralian therapeutic goods administrationBrazilian health regulatory agencyIsrael ministry of health pharmaceutical administrationEuropean union

Imfinzi Plus Chemotherapy Approved for Advanced Biliary Tract Cancer

The FDA has approved Imfinzi (durvalumab), in combination with gemcitabine and cisplatin, for the treatment of biliary tract cancer.

Medstar georgetown university hospitalDistrict of columbiaUnited statesGeorgetown lombardi comprehensive cancer centerGi cancer programDrug administrationAssociate professor

IMFINZI® (durvalumab) Plus Chemotherapy Approved in the US as the First Immunotherapy Regimen for Pa

Approval based on TOPAZ-1 Phase III trial results, which showed IMFINZI combination reduced risk of death by 20% vs. chemotherapy aloneWILMINGTON, Del. (BUSINESS WIRE) AstraZeneca’s IMFINZI® (durvalumab) has been approved in the US for the treatment of adult patients with locally advanced or metastatic biliary tra.

United statesUnited kingdomMedstar georgetown university hospitalDistrict of columbiaSouth koreaDave fredricksonJessica mcduellStacie lindseySouth east asiaDaiichi sankyoBrendan mcevoyGastroenterol hepatolCompany immunoNational comprehensive cancer network incGi cancer programCompany on twitter astrazeneca

IMFINZI® (durvalumab) plus chemotherapy approved in the US as the first immunotherapy regimen for patients with advanced biliary tract cancer

IMFINZI® (durvalumab) plus chemotherapy approved in the US as the first immunotherapy regimen for patients with advanced biliary tract cancer
astrazeneca-us.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from astrazeneca-us.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomMedstar georgetown university hospitalDistrict of columbiaSouth koreaDave fredricksonJessica mcduellStacie lindseySouth east asiaDaiichi sankyoBrendan mcevoyGastroenterol hepatolCompany immunoCompany on twitterNational comprehensive cancer network incGi cancer program